Drug intelligence / Profile preview

paracetamol + ibuprofen + famotidine

Development stage
Unknown
Lead developer
University Hospital Dubrava
Modality
Small Molecules
Administration
Oral
01

Overview

paracetamol + ibuprofen + famotidine is a combination therapy consisting of two analgesics with distinct mechanisms of action and a gastroprotective agent. Paracetamol (acetaminophen) is a non-opioid analgesic and antipyretic that primarily acts within the central nervous system to provide pain relief. Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase enzymes (COX-1 and COX-2), thereby reducing peripheral inflammation and pain. Famotidine is a histamine H2-receptor antagonist that competitively inhibits H2 receptors on gastric parietal cells, reducing gastric acid secretion. This triple combination is designed to provide potent multi-modal analgesia for conditions such as calcific tendinitis of the shoulder while minimizing the risk of NSAID-induced gastrointestinal complications, such as gastric ulcers and irritation.

Other names
acetaminophen + ibuprofen + famotidine
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)HRH2 (Histamine H2 Receptor)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on paracetamol + ibuprofen + famotidine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on paracetamol + ibuprofen + famotidine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call